CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)

This is an investigation of the efficacy and safety of CRD007 compared to placebo in the treatment of patients with abdominal aortic aneurysm.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Abdominal Aortic Aneurysm Aneurysm Aortic Aneurysm Aortic Aneurysm, Abdominal Aortic Diseases Cardiovascular Diseases Vascular Diseases

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Aalborg Hospital, Department of Vascular Surgery V, Aalborg, Denmark

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Infra-renal abdominal aortic aneurysm

Exclusion criteria

Previous infra-renal aortic surgery
Known diabetes

Treatment and study plan

CRD007

Drug

CRD007 matching placebo

Drug

Sponsors and collaborators

Lead sponsor

RSPR Pharma AB

Industry

Registry information

Official study title

An International, Multi-centre, Randomised, Stratified, Double-blinded, Placebo-controlled, 4-parallel Group Trial Investigating the Efficacy and Safety of Three Different Dose Levels of CRD007 (The AORTA Trial)

Important dates

First posted: May 16, 2011
Registry last updated: Nov 6, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed